OG-6219 for Endometriosis (ELENA Trial)

"This clinical trial is searching for participants aged 18 to 49."

"Wasatch Clinical Research in Salt Lake City, Northeast Clinical Research of San Antonio in San Antonio, and Paramount Research Solutions in College Park are some of the 13 sites currently signing on participants for this trial."

"For OG-6219 Dose 2, our team at Power estimates its safety to be a 2 as there is some evidence of security but no proof that it provides the desired therapeutic effect."

"Indeed, the clinical trial is recruiting as per information on clinicaltrials.gov. This medical study was first advertised on October 25th 2022 and updated December 9th 2022; its goal being to enrol 380 patients across 13 sites."

"Yes, the details published on clinicaltrials.gov affirm that this trial is currently admitting patients which it first advertised on October 25th 2022 and later updated on December 9th 2022. Altogether, 380 participants will be accepted across 13 medical sites."

"This medical trial is looking to recruit 380 pre-menopausal females aged 18 - 49 who have been surgically diagnosed with endometrioma and display moderate to severe symptoms. In addition, the candidate must be willing to forgo any other interventional studies while participating in this one, agree not to become pregnant by using two forms of non-hormonal contraception throughout the study, submit a signed informed consent form prior to enrolment, and be compliant with all necessary procedures as outlined by researchers."